Skip to main navigation Skip to search Skip to main content

Human lung adenocarcinoma α1,3/4-L-fucosyltransferase displays two molecular forms, high substrate affinity for clustered sialyl LacNAc type 1 units as well as mucin core 2 sialyl LacNAc type 2 unit and novel α1,2-L-fucosylating activity

  • E. V. Chandrasekaran
  • , Ram Chawda
  • , John M. Rhodes
  • , Jie Xia
  • , Conrad Piskorz
  • , Khushi L. Matta
  • Roswell Park Cancer Institute

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Human lung tumor α1,3/4-L-fucosyltransferase (FT) was purified (2000-fold, 29% recovery) from 290 g of tissue by including a chromatography step on Affinity Gel-GDP. Two molecular forms (FTA, larger size carrying 15% α1,4-FT activity; FTB, the major form with 85% activity) were separated by further fractionation on a Sephacryl S-100 HR column. A difference in the electrophoretic mobilities of these two activities was also found on native polyacrylamide gel electrophoresis (PAGE). Both forms were devoid of typical α1,2-fucosylating activity but were associated with the novel α1,2-fucosylating ability of converting the Lewis a determinant to Lewis b. Based on percentage activity toward 2-O-MeGalβ1,3GlcNAcβ-O-Bn, both forms exhibited the same extent of activity toward various acceptors, which included sulfated, sialylated, or methylated LacNAc type 1 or type 2 as well as mucin core 2 acceptors. However, FTA and FTB exhibited a difference in their ability to act on mucin core 2 3-sialyl LacNAc (activities 24.2% and 40.8%, respectively, as compared to 2-O-MeGalβ1,3GlcNAcβ-O-Bn). The unsubstituted LacNAc type 1 acceptors were 15-20 times as active as the corresponding LacNAc type 2 acceptors. The 3-O-substitution on the β1,4-linked Gal (methyl, sulfate, or sialyl) in mucin core 2 acceptors increased the efficiency of these acceptors five- to eightfold. The most efficient acceptor for FTA and FTB was 3-O-sulfoGalβ1,3GlcNAcβ-O-Al (Km 100 and 47 μM, respectively). The Km (mM) values for 2-O-methyl Galβ1,3GlcNAcβ-O-Bn and 3-O-sialyl Galβ1,3GlcNAcβ-O-Bn were 0.40 and 2.5 (FTA) and 0.16 and 0.67 (FTB), respectively. The 35-kDa glycoprotein ancrod (from Malayan pit viper venom) containing 36% complex N-glycans with the antennae NeuAcα2,3Galβ1,3GlcNAcβ- acted as the best macromolecular acceptor substrate (Km:45 μM), as examined with FTB. On desialylation the acceptor efficiency dropped to 50% (Km for asialo ancrod: 167 μM). Sialylglycoproteins, such as carcinoembryonic antigen, fetuin, and bovine α1-acid glycoprotein, were better acceptors than asialo fetuin. On the contrary, fetuin triantennary glycopeptide containing predominantly NeuAcα2,3Galβ1,4GlcNAcβ- was only 55% active as compared to the asialo glycopeptide (Km: 1.43 and 0.63 mM, respectively). Thus, the human lung tumor α1,3/4-L-FT has the potential to generate clustered sialyl Lewis a and Lewis b determinants in N-glycans and sialyl Lewis determinant in mucin core 2 structures.

Original languageEnglish
Pages (from-to)353-363
Number of pages11
JournalGlycobiology
Volume11
Issue number5
DOIs
StatePublished - 2001

Keywords

  • Fucosyltransferases
  • Kinetic properties
  • Mucinous lung adenocarcinoma
  • Sialyl Lewis a, x, and b determinants
  • Specificities

Fingerprint

Dive into the research topics of 'Human lung adenocarcinoma α1,3/4-L-fucosyltransferase displays two molecular forms, high substrate affinity for clustered sialyl LacNAc type 1 units as well as mucin core 2 sialyl LacNAc type 2 unit and novel α1,2-L-fucosylating activity'. Together they form a unique fingerprint.

Cite this